Cargando…
Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements
BACKGROUND: Information technology tools such as shared patient-centered, Web-based medication platforms hold promise to support safe medication use by strengthening patient participation, enhancing patients’ knowledge, helping patients to improve self-management of their medications, and improving...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893891/ https://www.ncbi.nlm.nih.gov/pubmed/29588269 http://dx.doi.org/10.2196/jmir.8666 |
_version_ | 1783313400104747008 |
---|---|
author | Bernhard, Gerda Mahler, Cornelia Seidling, Hanna Marita Stützle, Marion Ose, Dominik Baudendistel, Ines Wensing, Michel Szecsenyi, Joachim |
author_facet | Bernhard, Gerda Mahler, Cornelia Seidling, Hanna Marita Stützle, Marion Ose, Dominik Baudendistel, Ines Wensing, Michel Szecsenyi, Joachim |
author_sort | Bernhard, Gerda |
collection | PubMed |
description | BACKGROUND: Information technology tools such as shared patient-centered, Web-based medication platforms hold promise to support safe medication use by strengthening patient participation, enhancing patients’ knowledge, helping patients to improve self-management of their medications, and improving communication on medications among patients and health care professionals (HCPs). However, the uptake of such platforms remains a challenge also due to inadequate user involvement in the development process. Employing a user-centered design (UCD) approach is therefore critical to ensure that user’ adoption is optimal. OBJECTIVE: The purpose of this study was to identify what patients with type 2 diabetes mellitus (T2DM) and their HCPs regard necessary requirements in terms of functionalities and usability of a shared patient-centered, Web-based medication platform for patients with T2DM. METHODS: This qualitative study included focus groups with purposeful samples of patients with T2DM (n=25), general practitioners (n=13), and health care assistants (n=10) recruited from regional health care settings in southwestern Germany. In total, 8 semistructured focus groups were conducted. Sessions were audio- and video-recorded, transcribed verbatim, and subjected to a computer-aided qualitative content analysis. RESULTS: Appropriate security and access methods, supported data entry, printing, and sending information electronically, and tracking medication history were perceived as the essential functionalities. Although patients wanted automatic interaction checks and safety alerts, HCPs on the contrary were concerned that unspecific alerts confuse patients and lead to nonadherence. Furthermore, HCPs were opposed to patients’ ability to withhold or restrict access to information in the platform. To optimize usability, there was consensus among participants to display information in a structured, chronological format, to provide information in lay language, to use visual aids and customize information content, and align the platform to users’ workflow. CONCLUSIONS: By employing a UCD, this study provides insight into the desired functionalities and usability of patients and HCPs regarding a shared patient-centered, Web-based medication platform, thus increasing the likelihood to achieve a functional and useful system. Substantial and ongoing engagement by all intended user groups is necessary to reconcile differences in requirements of patients and HCPs, especially regarding medication safety alerts and access control. Moreover, effective training of patients and HCPs on medication self-management (support) and optimal use of the tool will be a prerequisite to unfold the platform’s full potential. |
format | Online Article Text |
id | pubmed-5893891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-58938912018-04-16 Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements Bernhard, Gerda Mahler, Cornelia Seidling, Hanna Marita Stützle, Marion Ose, Dominik Baudendistel, Ines Wensing, Michel Szecsenyi, Joachim J Med Internet Res Original Paper BACKGROUND: Information technology tools such as shared patient-centered, Web-based medication platforms hold promise to support safe medication use by strengthening patient participation, enhancing patients’ knowledge, helping patients to improve self-management of their medications, and improving communication on medications among patients and health care professionals (HCPs). However, the uptake of such platforms remains a challenge also due to inadequate user involvement in the development process. Employing a user-centered design (UCD) approach is therefore critical to ensure that user’ adoption is optimal. OBJECTIVE: The purpose of this study was to identify what patients with type 2 diabetes mellitus (T2DM) and their HCPs regard necessary requirements in terms of functionalities and usability of a shared patient-centered, Web-based medication platform for patients with T2DM. METHODS: This qualitative study included focus groups with purposeful samples of patients with T2DM (n=25), general practitioners (n=13), and health care assistants (n=10) recruited from regional health care settings in southwestern Germany. In total, 8 semistructured focus groups were conducted. Sessions were audio- and video-recorded, transcribed verbatim, and subjected to a computer-aided qualitative content analysis. RESULTS: Appropriate security and access methods, supported data entry, printing, and sending information electronically, and tracking medication history were perceived as the essential functionalities. Although patients wanted automatic interaction checks and safety alerts, HCPs on the contrary were concerned that unspecific alerts confuse patients and lead to nonadherence. Furthermore, HCPs were opposed to patients’ ability to withhold or restrict access to information in the platform. To optimize usability, there was consensus among participants to display information in a structured, chronological format, to provide information in lay language, to use visual aids and customize information content, and align the platform to users’ workflow. CONCLUSIONS: By employing a UCD, this study provides insight into the desired functionalities and usability of patients and HCPs regarding a shared patient-centered, Web-based medication platform, thus increasing the likelihood to achieve a functional and useful system. Substantial and ongoing engagement by all intended user groups is necessary to reconcile differences in requirements of patients and HCPs, especially regarding medication safety alerts and access control. Moreover, effective training of patients and HCPs on medication self-management (support) and optimal use of the tool will be a prerequisite to unfold the platform’s full potential. JMIR Publications 2018-03-27 /pmc/articles/PMC5893891/ /pubmed/29588269 http://dx.doi.org/10.2196/jmir.8666 Text en ©Gerda Bernhard, Cornelia Mahler, Hanna Marita Seidling, Marion Stützle, Dominik Ose, Ines Baudendistel, Michel Wensing, Joachim Szecsenyi. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 27.03.2018. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Bernhard, Gerda Mahler, Cornelia Seidling, Hanna Marita Stützle, Marion Ose, Dominik Baudendistel, Ines Wensing, Michel Szecsenyi, Joachim Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements |
title | Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements |
title_full | Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements |
title_fullStr | Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements |
title_full_unstemmed | Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements |
title_short | Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements |
title_sort | developing a shared patient-centered, web-based medication platform for type 2 diabetes patients and their health care providers: qualitative study on user requirements |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893891/ https://www.ncbi.nlm.nih.gov/pubmed/29588269 http://dx.doi.org/10.2196/jmir.8666 |
work_keys_str_mv | AT bernhardgerda developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements AT mahlercornelia developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements AT seidlinghannamarita developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements AT stutzlemarion developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements AT osedominik developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements AT baudendistelines developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements AT wensingmichel developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements AT szecsenyijoachim developingasharedpatientcenteredwebbasedmedicationplatformfortype2diabetespatientsandtheirhealthcareprovidersqualitativestudyonuserrequirements |